Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vistagen Therapeutics (VTGN) Change in Acquisitions & Divestments (2024 - 2025)

Historic Change in Acquisitions & Divestments for Vistagen Therapeutics (VTGN) over the last 2 years, with Q4 2025 value amounting to $6.0 million.

  • Vistagen Therapeutics' Change in Acquisitions & Divestments rose 20015.01% to $6.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $20.5 million, marking a year-over-year increase of 17384.29%. This contributed to the annual value of $12.0 million for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Vistagen Therapeutics' Change in Acquisitions & Divestments is $6.0 million, which was up 20015.01% from $2.0 million recorded in Q3 2025.
  • Over the past 5 years, Vistagen Therapeutics' Change in Acquisitions & Divestments peaked at $8.0 million during Q2 2025, and registered a low of $2.0 million during Q4 2024.